Brief: Adocia Initiates BC LisPram Phase 1 Clinical Trial In Pump For People With Type 1 Diabetes
June 29 (Reuters) - ADOCIA SA ADOC.PA :
* ADOCIA INITIATES BC LISPRAM PHASE 1 CLINICAL TRIAL IN PUMP
FOR
PEOPLE WITH TYPE 1 DIABETES
* FOR FIRST TIME, A UNIQUE COMBINATION OF TWO KEY HORMONES
INVOLVED IN GLYCEMIC CONTROL, A RAPID ACTING INSULIN ANALOG AND
AN AMYLIN ANALOG, IS TESTED IN A SINGLE PUMP
Source text for Eikon: ID:nBw9sKnpHa
Further company coverage: ADOC.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Adocia SA
See all newsBrief: Adocia And Vester Finance Sign Shareholder Loan Agreement
Brief: Adocia Sees Challenges With GLP-1, Amylin & Other Metabolic Peptides
Brief: Adocia H1 Operating Income EUR -8.932 Million
Brief: Adocia, Tonghua Dongbao Reports Positive Phase 3 Results For Ultra-Rapid Insulin In T2D
Brief: Adocia And Tonghua Dongbao Announce Final Dosing In Phase 3 Clinical Study Of Biochaperone® Lispro